Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

ImExHS (ASX:IME) Slides Sharply: Is IME Facing a Reality Check on the ASX?

ImExHS (ASX:IME) drew fresh attention on 10 July 2026 after appearing among the ASX stocks that fell most sharply in percentage terms during the session. For a company of ImExHS’s size, a single day of heavy selling can look dramatic on a chart even …

Aditi Sarkar | 10 July 2026

Dimerix (ASX:DXB) Drops as Biotech Traders Watch the Next Catalyst

Dimerix (ASX: DXB) drew attention on 10 July 2026 amid a session in which biotech traders appeared focused on the timing of the next meaningful catalyst for the company. Clinical-stage biotechnology stocks tend to trade in a distinctive rhythm: share prices can build up …

Aditi Sarkar | 10 July 2026

Cochlear (ASX:COH) Pulls Back as ASX Healthcare Giants Face a Softer Session

Cochlear is one of the best-known names in Australian healthcare, and on 10 July 2026 it was among the ASX stocks drawing attention during a session in which healthcare giants appeared to face softer trading. As a large, premium-rated company, Cochlear can be sensitive …

Aditi Sarkar | 10 July 2026

CLEO Diagnostics (ASX:COV) Slips as ASX Biotech Volatility Stays in Focus

This article examines what CLEO Diagnostics does, why the stock may be attracting attention, the sector conditions that could be shaping trading, and the balance of risks and catalysts investors may be weighing. None of it is a recommendation. The aim is to set …

Aditi Sarkar | 10 July 2026

CSL (ASX:CSL) Pulls Back as ASX Healthcare Heavyweights Face Renewed Scrutiny

CSL (ASX: CSL) commands attention on the Australian market for the simple reason that it is one of the country’s most significant listed companies. When a stock of that scale features among the day’s movers, it tends to influence the broader market and draw …

Aditi Sarkar | 10 July 2026

Clinuvel Pharmaceuticals (ASX:CUV) Slips as Biotech Investors Watch Valuation Risk

HighlightsClinuvel Pharmaceuticals (ASX: CUV) came into focus after its share price appeared to come under pressure during a session marked by broader caution, prompting renewed attention on the biopharma group.The company’s commercial foundation is SCENESSE (afamelanotide), a therapy approved for the prevention of phototoxicity …

Aditi Sarkar | 10 July 2026

EchoIQ (ASX:EIQ) Climbs as AI-Linked Healthcare Stocks Stay on Watch

Attention has turned to EchoIQ (ASX: EIQ) after the AI-enabled medical diagnostics company's shares advanced, placing the stock back on the radar of some ASX traders.

Sonal Goyal | 10 July 2026

Compumedics (ASX:CMP) Jumps as Health-Tech Investors Revisit ASX Growth Names

Compumedics (ASX: CMP) has drawn fresh attention from ASX market participants after the stock moved higher, prompting some traders and investors to take a closer look at the medical-device technology company.

Sonal Goyal | 10 July 2026

Singular Health (ASX:SHG) Rises as Digital Health Stocks Return to the Watchlist

Singular Health (ASX: SHG) has become one of the names capturing attention on the Australian Securities Exchange, with the stock moving higher and market interest appearing to build around the digital health and medical imaging company. In the sections that follow, this article examines …

Sonal Goyal | 10 July 2026

Proteomics International (ASX:PIQ) Surges: Could PIQ Be the Next ASX Biotech Stock to Watch?

Proteomics International (ASX: PIQ) has become one of the names capturing attention on the Australian Securities Exchange, with the stock moving higher and market interest appearing to build around the medical diagnostics and proteomics company. In the sections that follow, this article examines why …

Sonal Goyal | 10 July 2026
Support

Hi! How can we help you today?

Loading…